Are PCSK9 Inhibitors Cost Effective?

PharmacoEconomics - United Kingdom
doi 10.1007/s40273-018-0671-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC